CSPC Pharmaceutical Group (1093N) Stock Forecast & Price Target
1093N Analyst Ratings
Strong Buy
11Buy0Hold1Sell
Based on 12 analysts giving stock ratings to CSPC Pharmaceutical Group in the past 3 months
1093N Stock 12 Month Forecast
Average Price Target
MXN 32.88▲(105.48% Upside)Based on 12 Wall Street analysts offering 12 month price targets for CSPC Pharmaceutical Group in the last 3 months. The average price target is MXN 32.88 with a high forecast of MXN 46.37 and a low forecast of MXN 19.16. The average price target represents a 105.48% change from the last price of MXN 16.00.
Past 12 Months12 Month ForecastJan2026Oct2026
HighMXN 46.37
AverageMXN 32.88
LowMXN 19.16
Highest Price TargetHighestMXN 46.37Average Price TargetMXN 32.88Lowest Price TargetLowestMXN 19.16
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | UBS | MXN 28.26 | buy | 76.65%Upside | Reiterated | 10/28/26 | ||
| Mark Kong CFA | DBS | MXN 32.82 | buy | 105.10%Upside | Initiated | 09/10/26 | ||
| Unknown AnalystNot Ranked | Citic Securities | MXN 43.12 | buy | 169.47%Upside | Reiterated | 08/25/26 | ||
| Chu Wang | Jefferies | MXN 19.16 | sell | 19.76%Upside | Reiterated | 08/24/26 | ||
| Unknown AnalystNot Ranked | CICC | MXN 28.74 | buy | 79.65%Upside | Reiterated | 08/22/26 | ||
| Jill Wu | CMB International Securities | MXN 31.26→MXN 32.19 | buy | 101.20%Upside | Reiterated | 08/21/26 | ||
| Unknown AnalystNot Ranked | CLSA | MXN 45.51 | buy | 184.44%Upside | Reiterated | 08/21/26 | ||
| John Yung | Citi | MXN 27.55→MXN 33.53 | buy | 109.59%Upside | Reiterated | 08/21/26 | ||
| Unknown AnalystNot Ranked | Huatai Securities | MXN 46.37 | buy | 189.83%Upside | Reiterated | 08/21/26 | ||
| Alexis Yan | Morgan Stanley | MXN 26.35 | buy | 64.68%Upside | Reiterated | 08/20/26 | ||
| Unknown AnalystNot Ranked | Guosheng Securities | MXN 32.12 | buy | 100.75%Upside | Reiterated | 08/19/26 | ||
| Unknown AnalystNot Ranked | Daiwa | MXN 26.35 | buy | 64.68%Upside | Reiterated | 08/12/26 | ||
| Unknown AnalystNot Ranked | Nomura | MXN 24.70 | buy | 54.35%Upside | Reiterated | 07/24/26 | ||
| Unknown AnalystNot Ranked | HSBC | MXN 22.16 | buy | 38.48%Upside | Reiterated | 07/10/26 | ||
| Unknown AnalystNot Ranked | BOCOM International Holdings Company | MXN 19.28 | hold | 20.51%Upside | Reiterated | 06/02/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Unknown AnalystNot Ranked | 10/28/26 | MXN 28.26 | buy | 76.65%Upside | Reiterated | UBS | ||
| Mark Kong CFA | 09/10/26 | MXN 32.82 | buy | 105.10%Upside | Initiated | DBS | ||
| Unknown AnalystNot Ranked | 08/25/26 | MXN 43.12 | buy | 169.47%Upside | Reiterated | Citic Securities | ||
| Chu Wang | 08/24/26 | MXN 19.16 | sell | 19.76%Upside | Reiterated | Jefferies | ||
| Unknown AnalystNot Ranked | 08/22/26 | MXN 28.74 | buy | 79.65%Upside | Reiterated | CICC | ||
| Jill Wu | 08/21/26 | MXN 31.26→MXN 32.19 | buy | 101.20%Upside | Reiterated | CMB International Securities | ||
| Unknown AnalystNot Ranked | 08/21/26 | MXN 45.51 | buy | 184.44%Upside | Reiterated | CLSA | ||
| John Yung | 08/21/26 | MXN 27.55→MXN 33.53 | buy | 109.59%Upside | Reiterated | Citi | ||
| Unknown AnalystNot Ranked | 08/21/26 | MXN 46.37 | buy | 189.83%Upside | Reiterated | Huatai Securities | ||
| Alexis Yan | 08/20/26 | MXN 26.35 | buy | 64.68%Upside | Reiterated | Morgan Stanley | ||
| Unknown AnalystNot Ranked | 08/19/26 | MXN 32.12 | buy | 100.75%Upside | Reiterated | Guosheng Securities | ||
| Unknown AnalystNot Ranked | 08/12/26 | MXN 26.35 | buy | 64.68%Upside | Reiterated | Daiwa | ||
| Unknown AnalystNot Ranked | 07/24/26 | MXN 24.70 | buy | 54.35%Upside | Reiterated | Nomura | ||
| Unknown AnalystNot Ranked | 07/10/26 | MXN 22.16 | buy | 38.48%Upside | Reiterated | HSBC | ||
| Unknown AnalystNot Ranked | 06/02/26 | MXN 19.28 | hold | 20.51%Upside | Reiterated | BOCOM International Holdings Company |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering CSPC Pharmaceutical Group
3 Months
Success Rate10/16 ratings generated profit
63%
Average Return
+11.11%
Copying Jill Wu's trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +11.11% per trade.
1 Year
Success Rate11/16 ratings generated profit
69%
Average Return
+26.26%
Copying Jill Wu's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +26.26% per trade.
2 Years
Success Rate14/16 ratings generated profit
88%
Average Return
+43.82%
Copying Jill Wu's trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +43.82% per trade.
1093N Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 7 | 7 | 1 |
| Buy | 7 | 9 | 8 | 5 | 1 |
| Hold | 1 | 1 | 0 | 0 | 0 |
| Sell | 2 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 18 | 18 | 16 | 13 | 2 |
In the current month, 1093N has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1093N average Analyst price target in the past 3 months is 32.88.
1093N Financial Forecast
HighMXN 0.39
ConsensusMXN 0.23
LowMXN 0.06
1093N Earnings Forecast
Next quarter’s earnings estimate for 1093N is MXN 0.23 with a range of MXN 0.06 to MXN 0.39. The previous quarter’s EPS was MXN 1.30. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 19.5B
ConsensusMXN 18.8B
LowMXN 17.6B
1093N Sales Forecast
Next quarter’s sales forecast for 1093N is MXN 18.80B with a range of MXN 17.55B to MXN 19.49B. The previous quarter’s sales results were MXN 50.77B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
1093N Stock Forecast FAQ
What is MX:1093N’s average 12-month price target, according to analysts?
Based on analyst ratings, CSPC Pharmaceutical Group’s 12-month average price target is Mex$32.88.
What is MX:1093N’s upside potential, based on the analysts’ average price target?
CSPC Pharmaceutical Group has 105.48% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CSPC Pharmaceutical Group a Buy, Sell or Hold?
CSPC Pharmaceutical Group has a consensus rating of Strong Buy, which is based on 11 buy ratings, 0 hold ratings and 1 sell ratings.
What is CSPC Pharmaceutical Group’s share price target?
The average share price target for CSPC Pharmaceutical Group is Mex$32.88. This is based on 12 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$46.37, and the lowest forecast is Mex$19.16. The average share price target represents a 105.48% increase from the current price of Mex$16.
What do analysts say about CSPC Pharmaceutical Group?
CSPC Pharmaceutical Group’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Street analysts.
How can I buy shares of CSPC Pharmaceutical Group?
To buy shares of MX:1093N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
